Utilizzo della azitromicina e.v. nel trattamento delle polmoniti acquisite in comunità

Translated title of the contribution: Intravenous azithromycin in the treatment of community-acquired pneumonia

F. Di Marco, F. Blasi, S. Centanni

Research output: Contribution to journalArticle

Abstract

Azithromycin, actually available both intravenously and orally, is indicated in the treatment of outpatients and inpatients with cardiopulmonary disease or with and without modifying factors that increase the risk of infection with specific pathogens. Intravenous azithromycin (IA) is effective in case of bacteriemia since it reaches high serum concentration; moreover IA has a good local and systemic tolerability. An analysis limited to drugs' cost showed that intravenous azithromycin/beta-lactam combination is less expensive that monotherapy with intravenous levofloxacin.

Translated title of the contributionIntravenous azithromycin in the treatment of community-acquired pneumonia
Original languageItalian
Pages (from-to)261-268
Number of pages8
JournalGIMT - Giornale Italiano delle Malattie del Torace
Volume56
Issue number4
Publication statusPublished - 2002

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Intravenous azithromycin in the treatment of community-acquired pneumonia'. Together they form a unique fingerprint.

  • Cite this